Vidal C, Romero L, Lopez-Freire S, Carballada-Gonzalez F, Garcia-Robaina J, Gonzalez-Fernandez T
Immun Inflamm Dis. 2024; 12(12):e70090.
PMID: 39698951
PMC: 11656404.
DOI: 10.1002/iid3.70090.
Spiewak R, Gregorius A, Ostrowski G, Czarnobilska E
Int J Mol Sci. 2024; 25(18).
PMID: 39337447
PMC: 11432158.
DOI: 10.3390/ijms25189959.
Wan W, Xu Q, Lu M, Lyu Q, Gu Z, Yuan J
World Allergy Organ J. 2024; 17(7):100926.
PMID: 39040084
PMC: 11261089.
DOI: 10.1016/j.waojou.2024.100926.
Ojeda P, Barjau M, Subiza J, Moreno A, Ojeda I, Solano E
Front Immunol. 2024; 15:1431351.
PMID: 38989287
PMC: 11233432.
DOI: 10.3389/fimmu.2024.1431351.
Pan M, Xue J
Immunotherapy. 2024; 16(11):749-758.
PMID: 38957931
PMC: 11421298.
DOI: 10.1080/1750743X.2024.2365619.
Satisfaction, Qol and adherence of patients allergic to dust mites and/or pollens undergoing sublingual immunotherapy.
Garrido-Fernandez S, Fernandez D, Lopez G, Mar Escribano Rodriguez M, Delgado V, Iglesias-Souto J
Immunotherapy. 2024; 16(10):693-704.
PMID: 38888502
PMC: 11404694.
DOI: 10.1080/1750743X.2024.2347828.
The safety and tolerability of a one strength dose-escalation scheme for subcutaneous immunotherapy with a native house dust mite extract in Chinese children: A multicenter, randomized, open label clinical trial.
Zhi L, Bai Y, Liao W, Chen G, Gao T, Wan X
Heliyon. 2024; 10(8):e29450.
PMID: 38655350
PMC: 11036000.
DOI: 10.1016/j.heliyon.2024.e29450.
Respiratory allergic diseases and allergen immunotherapy: A French patient survey before and during the COVID-19 pandemic.
Devillier P, Saf S, Rolland C, Canonica G, Demoly P
World Allergy Organ J. 2024; 17(4):100902.
PMID: 38623320
PMC: 11017353.
DOI: 10.1016/j.waojou.2024.100902.
Increased Nasal Blimp1 + Treg Cells After Sublingual Immunotherapy Reflect the Efficacy of Treatment in Allergic Rhinitis.
Pan Y, Zhang X, Geng H, Yu Y, Liu J, Li M
Adv Ther. 2024; 41(4):1698-1710.
PMID: 38443650
DOI: 10.1007/s12325-024-02819-8.
Allergen immunotherapy in China.
Yang Y, Li W, Zhu R
Front Allergy. 2024; 4:1324844.
PMID: 38260178
PMC: 10801290.
DOI: 10.3389/falgy.2023.1324844.
KAAACI Guidelines for Allergen Immunotherapy.
Lee H, Lee S, Kang S, Kim K, Kim J, Ryu G
Allergy Asthma Immunol Res. 2023; 15(6):725-756.
PMID: 37957792
PMC: 10643862.
DOI: 10.4168/aair.2023.15.6.725.
Efficacy and Safety of Subcutaneous Allergen-Specific Immuno-Therapy in Horses with Allergic Cutaneous and Respiratory Diseases-A Systematic Review.
Herrmann I, Sanchez A
Vet Sci. 2023; 10(10).
PMID: 37888565
PMC: 10611411.
DOI: 10.3390/vetsci10100613.
United States Drug Allergy Registry (USDAR) grading scale for immediate drug reactions.
Khan D, Phillips E, Accarino J, Gonzalez-Estrada A, Otani I, Ramsey A
J Allergy Clin Immunol. 2023; 152(6):1581-1586.
PMID: 37652140
PMC: 10872843.
DOI: 10.1016/j.jaci.2023.08.018.
Efficacy and immunological changes of sublingual immunotherapy in pediatric allergic rhinitis.
Zeng Y, Xiao H, Gao S, Li J, Yang C, Zeng Q
World Allergy Organ J. 2023; 16(7):100803.
PMID: 37520614
PMC: 10382672.
DOI: 10.1016/j.waojou.2023.100803.
Identification of key genes and the pathophysiology associated with allergen-specific immunotherapy for allergic rhinitis.
Fan K, Zhou S, Jin L, Tan S, Lai J, Zhang Z
BMC Immunol. 2023; 24(1):19.
PMID: 37430199
PMC: 10334648.
DOI: 10.1186/s12865-023-00556-1.
Adverse events in children and adolescents undergoing allergen immunotherapy for respiratory allergies-Report from the Allergen Immunotherapy Adverse Events Registry (ADER), a European Academy of Allergy and Clinical Immunology taskforce.
Asllani J, Mitsias D, Konstantinou G, Mesonjesi E, Xhixha F, Shehu E
Clin Transl Allergy. 2023; 13(6):e12250.
PMID: 37357552
PMC: 10236500.
DOI: 10.1002/clt2.12250.
Vaccination against infectious agents and allergen-specific immunotherapy: A critical analysis.
Worm M, Pfaar O
Allergol Select. 2023; 7:84-89.
PMID: 37056445
PMC: 10088876.
DOI: 10.5414/ALX02390E.
Nasal cytology can predict clinical efficacy of subcutaneous immunotherapy in intermittent allergic rhinitis.
Jura-Szoltys E, Gawlik R, Branicka O, Stryjewska-Makuch G, Gluck J
Postepy Dermatol Alergol. 2023; 39(6):1110-1115.
PMID: 36686010
PMC: 9837575.
DOI: 10.5114/ada.2022.117978.
Chinese Guideline on Allergen Immunotherapy for Allergic Rhinitis: The 2022 Update.
Wang C, Bao Y, Chen J, Chen X, Cheng L, Guo Y
Allergy Asthma Immunol Res. 2022; 14(6):604-652.
PMID: 36426395
PMC: 9709690.
DOI: 10.4168/aair.2022.14.6.604.
Guideline on allergen immunotherapy in IgE-mediated allergic diseases: S2K Guideline of the German Society of Allergology and Clinical Immunology (DGAKI), Society of Pediatric Allergology and Environmental Medicine (GPA), Medical Association of....
Pfaar O, Ankermann T, Augustin M, Bubel P, Boing S, Brehler R
Allergol Select. 2022; 6:167-232.
PMID: 36178453
PMC: 9513845.
DOI: 10.5414/ALX02331E.
